Massachusetts Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$164M Buy
496,004
+697
+0.1% +$237K 0.06% 281
2025
Q4
$197M Buy
495,307
+138,778
+39% +$61.4M 0.06% 270
2025
Q3
$163M Buy
+356,529
New +$145M 0.05% 315
2024
Q1
Sell
-112,240
Closed -$21.5M 841
2023
Q4
$21.5M Sell
112,240
-575,988
-84% -$98.1M 0.01% 563
2023
Q3
$122M Buy
688,228
+15,831
+2% +$3.02M 0.04% 332
2023
Q2
$128M Sell
672,397
-93,375
-12% -$18.5M 0.04% 327
2023
Q1
$153M Buy
765,772
+10,230
+1% +$2.15M 0.05% 281
2022
Q4
$180M Buy
755,542
+219,943
+41% +$46.9M 0.06% 252
2022
Q3
$107M Buy
535,599
+191,310
+56% +$36.5M 0.04% 327
2022
Q2
$50.2M Buy
344,289
+41,546
+14% +$5.89M 0.02% 453
2022
Q1
$49.4M Sell
302,743
-1,019,468
-77% -$155M 0.01% 483
2021
Q4
$224M Sell
1,322,211
-43,076
-3% -$8.01M 0.06% 259
2021
Q3
$258M Sell
1,365,287
-9,856
-0.7% -$1.85M 0.08% 223
2021
Q2
$233M Sell
1,375,143
-86,919
-6% -$12.7M 0.07% 240
2021
Q1
$206M Sell
1,462,062
-301,305
-17% -$45.3M 0.06% 254
2020
Q4
$229M Sell
1,763,367
-142,023
-7% -$19M 0.07% 227
2020
Q3
$277M Buy
1,905,390
+842,211
+79% +$120M 0.1% 192
2020
Q2
$157M Buy
+1,063,179
New +$143M 0.06% 244
2016
Q4
Sell
-78,048
Closed -$5.29M 855
2016
Q3
$5.29M Buy
78,048
+767
+1% +$54.1K ﹤0.01% 641
2016
Q2
$4.29M Sell
77,281
-2,697
-3% -$170K ﹤0.01% 656
2016
Q1
$5.02M Buy
79,978
+985
+1% +$65.5K ﹤0.01% 641
2015
Q4
$7.44M Sell
78,993
-537
-0.7% -$49.8K ﹤0.01% 613
2015
Q3
$6.39M Sell
79,530
-1,472
-2% -$164K ﹤0.01% 643
2015
Q2
$9.71M Sell
81,002
-1,268
-2% -$152K ﹤0.01% 617
2015
Q1
$8.59M Buy
82,270
+2,548
+3% +$258K ﹤0.01% 628
2014
Q4
$7.73M Buy
+79,722
New +$7.39M ﹤0.01% 638

Other funds holding ALNY